OpenAlex
PricingAboutJobs
Log inGet started
Author

zhe Hong

Observed name: Zhe Hong
Institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center, Shanghai Cancer Institute
Observed institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center, Shanghai Cancer Institute
ORCID: 0000-0001-5942-4893
Observed ORCID: 0000-0001-5942-4893
OpenAlex ID: A5017092769
METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7/DNA2 axis and mitophagy regulation
2026 · Ruifeng Yang, Qintao Ge, et al. · Oncogene
Correction: Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide
2026 · Junhong Li, Zhe Hong, et al. · Oncogene
PDF
BET inhibitor blocks the oncogenic function of nucleophosmin 1 in castration-resistant prostate cancer by interfering with the c-Myc signaling pathway
2022 · zhe Hong, Chengdang Xu, et al. · Research Square
PDF
APOL3 Orchestrates Metastasis and Enzalutamide Resistance via STAT3-DAB2IP Signaling in Prostate Cancer
1970 · Quanxin Wang, Songlin Zuo, et al. · Current Gene Therapy
Works count: 4
Citation count:
H-index:
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security